Latest Due Diligence News

Power Minerals Limited has secured an option to acquire the Gamma Heavy Rare Earths Project in California, adjacent to the Mountain Pass Mine, backed by a $4.1 million placement to accelerate exploration.

Adamantem Capital Management has completed its due diligence on Apiam Animal Health and extended its exclusivity period to negotiate a potential $0.87 per share acquisition. The deal remains subject to approvals and binding agreements.

Australian Wealth Advisors Group Ltd (AWAG) has acquired a 20% stake in First Mutual Australia, marking a key step toward doubling its authorised representatives by mid-2026. This earnings accretive move underpins AWAG’s strategy to build a boutique ‘house of brands’ in financial advisory.

Asian Battery Metals PLC’s latest Phase 3 drilling results at the Yambat Project in Mongolia reveal expanded copper-nickel mineralisation and new high-conductance electromagnetic targets, underscoring the district-scale potential of this emerging magmatic sulphide system.

Stakk Limited has successfully raised $15 million through an oversubscribed equity placement, underscoring strong institutional confidence in its Embedded Finance growth strategy. The funds will accelerate expansion in the U.S. and Australian markets as the company’s recurring revenue surges.

Warriedar Resources has sent out the Scheme Booklet to shareholders detailing its proposed acquisition of Capricorn Metals, with the Board unanimously recommending approval. Key meetings and court dates are set as the company moves toward a significant corporate milestone.

Felix Gold Limited has been found in breach of ASX continuous disclosure rules after delaying the announcement of a U.S. federal site visit to its Alaska antimony project, prompting an internal review of its disclosure policies.

Summit Minerals Limited has announced a fully underwritten entitlement offer to raise approximately $1.08 million, aimed at advancing its Brazilian exploration projects and funding potential acquisitions. The offer, priced at $0.03 per share, is open to Australian and New Zealand shareholders and is expected to dilute non-participating shareholders by about 25%.

Invex Therapeutics has ended negotiations on two neurological asset acquisitions following due diligence setbacks and shareholder disputes, while advancing R&D collaborations and managing financial stability.

Impact Minerals has partnered with Kuniko Limited, granting them the right to earn up to 70% of the Commonwealth gold-silver project in NSW’s Lachlan Fold Belt through a $3 million exploration commitment over four years.

Evergreen Lithium has identified multiple compelling gold targets at its Mt Monger Gold Project, leveraging strong historic drilling and prime infrastructure to fast-track development plans.

Anatara Lifesciences has raised $1.2 million through a discounted share placement to fund its Anti-Obesity project and explore new opportunities. The capital injection reflects strong institutional support amid ongoing pipeline development.